Boehringer Ingelheim Animal Health USA has entered a strategic collaboration with Alizent, a subsidiary of Air Liquide, to implement an innovative cold chain tracking solution to enhance poultry vaccine supply chain management.
Some poultry vaccines are frozen at -200 degrees and shipped in containers, known as Dewars, filled with liquid nitrogen (LN2) to maintain the cold temperature during transit and protect the efficacy of live cells inside the vaccines.
The collaboration taps into the growing interconnectivity of the Internet of Things (IoT) by using Alizent’s SmartDewar IoT platform to track Dewars housing liquid nitrogen and cryogenic samples, such as poultry vaccines.
Read more about poultry vaccines:
Protecting against poultry diseases with 3-in-1 vaccine
Vaccination – getting the most out of it
Things to consider in in-ovo vaccination
It will also monitor the level of liquid nitrogen in the container and provide temperature alerts.
The SmartDewar technology gives Boehringer tools to constantly monitor the cold chain to help ensure product integrity, improve the efficiency of the supply network, and accelerate the development of transformative digital solutions.
“This novel cryogenic cold chain tracking solution developed with Alizent allows continuous monitoring and greater visibility of the supply chain to help ensure product integrity and monitor supply network performance,” said Claudia Garcia, Head of Global Strategic Poultry Marketing at Boehringer Ingelheim Animal Health.
“With the convergence of IoT sensors and cloud technologies backed by global wireless connectivity, this new solution can be a game changer for the transportation of the vaccine supply supporting poultry producers.”
